Expression profiling of DNA methyl transferase I (DNMT1) and efficacy of a DNA-hypomethylating agent (decitabine) in combination with chemotherapy in osteosarcoma

Endoplasmic reticulum protein 29 (ERp29) as a novel prognostic marker and tumor suppressor in osteosarcoma

(2019) Parunya Chaiyawat et al.   Journal of Bone Oncology

MiR-139-5p suppresses osteosarcoma cell growth and invasion through regulating DNMT1

(2018) Yong-Kang Shi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Activation of PAR4 Upregulates p16 through Inhibition of DNMT1 and HDAC2 Expression via MAPK Signals in Esophageal Squamous Cell Carcinoma Cells

(2018) Ming Wang et al.   Journal of Immunology Research

A novel interplay between HOTAIR and DNA methylation in osteosarcoma cells indicates a new therapeutic strategy

(2017) Xingang Li et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma

(2017) Parunya Chaiyawat et al.   Translational Oncology

Exploring targeted therapy of osteosarcoma using proteomics data

(2017) Parunya Chaiyawat et al.   OncoTargets and Therapy

DNMT1 overexpression predicting gastric carcinogenesis, subsequent progression and prognosis: a meta and bioinformatic analysis

(2017) Tianmiao Ma et al.   Oncotarget

Drug combination therapy increases successful drug repositioning

(2016) Wei Sun et al.   DRUG DISCOVERY TODAY

Overexpression of KH-type splicing regulatory protein regulates proliferation, migration, and implantation ability of osteosarcoma

(2016) Dumnoensun Pruksakorn et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

(2016) John S. Welch et al.   NEW ENGLAND JOURNAL OF MEDICINE

Silencing DNA methyltransferase 1 (DNMT1) inhibits proliferation, metastasis and invasion in ESCC by suppressing methylation of RASSF1A and DAPK

(2016) Jian Bai et al.   Oncotarget

Searching for Drug Synergy in Complex Dose–Response Landscapes Using an Interaction Potency Model

(2015) Bhagwan Yadav et al.   Computational and Structural Biotechnology Journal

Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumors

(2014) Jing Nie et al.   CANCER LETTERS

DNA Methyltransferases: A Novel Target for Prevention and Therapy

(2014) Dharmalingam Subramaniam et al.   Frontiers in Oncology

Epigenetic Resensitization to Platinum in Ovarian Cancer

(2012) D. Matei et al.   CANCER RESEARCH

A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer

(2010) Fang Fang et al.   CANCER

Azacitidine enhances sensitivity of platinum-resistant ovarian cancer cells to carboplatin through induction of apoptosis

(2008) Yanfang Li et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Evolution of decitabine development

(2008) Elias Jabbour et al.   CANCER